This is the first study revealing that GDF15 concentrations are significantly altered in adults with having both-cognitive-frailty-and-depression and that high plasma GDF15 concentrations are significantly associated with a higher occurrence and likelihood of both-cognitive-frailty-and-depression in adults independently of age, BMI, sex, comorbidities and hsCRP. This evidence concerns the gene GDF15 and major depressive disorder.